Navigation Links
ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
Date:5/19/2011

ults of the Phase 2 study may not be predictive of how VP 20621 will perform in future studies. There can be no assurance that we will conduct additional studies with VP 20621 in the timeframes we expect or at all, or that VP 20621 can significantly reduce the incidence of recurrent disease for patients with CDI. The FDA or EMA may view the data regarding VP 20621 as insufficient or inconclusive, request additional data, require additional clinical studies, delay any decision past the time frames anticipated by us, limit any approved indications, or deny the approval of VP 20621. These factors, and other factors, including, but not limited to those described in ViroPharma's annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission during 2010, could cause future results to differ materially from the expectations expressed in this press release. The forward-looking statements contained in this press release may become outdated over time. ViroPharma does not assume any responsibility for updating any forward-looking statements.  These forward-looking statements should not be relied upon as representing our assessments as of any date subsequent to the date of this press release.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... Connected health infrastructure is emerging as ... aiding diagnosis, monitoring and prevention in the healthcare ... stakeholders must first ensure that interoperability and connectivity ... http://photos.prnewswire.com/prnh/20150526/218313LOGO New analysis ... Connectivity and Interoperability, finds that the adoption of ...
(Date:5/26/2015)... 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: IN; ... a provisional patent application with the United States ... treatment of Epidermolysis Bullosa Simplex (EBS) using novel ... Dr. Sazzad Hossain , ... excited to file our first patent covering the ...
(Date:5/22/2015)... May 22, 2015  Research and Benchmarking firm, ... Medical Affairs Roundtable on Thursday, May ... virtual roundtable to discuss "Medical Affairs, Role in ... Practices, Medical Affairs Consortium provides Medical Affairs leaders ... key challenges they face. The consortium has developed ...
Breaking Medicine Technology:Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 3InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3Best Practices Sixth Medical Affairs Consortium Roundtable to Focus on Health Economics & Outcomes Research 2
(Date:5/26/2015)... Pass, OR (PRWEB) May 26, 2015 ... always fatal if not caught early. Melanoma is also ... water advocate Sharon Kleyne, the melanoma rate is on ... radiation. While the melanoma risk for indoor tanning salon ... these establishments. The most recent ban, in Pennsylvania, coincides ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 General ... with MarkLogic Corporation. The alliance ensures joint customers ... platform and General Networks’ expertise in building enterprise ... and MarkLogic will help customers integrate, manage and ... and business processes. , “Our customers are seeking ...
(Date:5/26/2015)... 26, 2015 Javon Bea President ... responsible for using her quality improvement and organizational development ... Denise also provides leadership and direction for the financial, ... Mercy Home Health Care and Mercy Durable Medical Equipment. ... care administration with the last 20 in home care ...
(Date:5/26/2015)... Boston, MA. (PRWEB) May 26, 2015 ... Standing option in their online Master of Social ... Program sites and on the Charles River Campus, the ... , This Advanced Standing option is open ... by the Council on Social Work Education. Students entering ...
Breaking Medicine News(10 mins):Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 2Health News:Boston University to Offer Online Master of Social Work Advanced Standing Option 3
... an interesting manifestation of post traumatic stress disorder (PTSD) - ... frequented chat rooms while at work, his employers, the ... the 58-year old James Pacenza is suing them for $ ... IBM should have offered him sympathy and treatment instead of ...
... report [Thursday, 24 May 2007] the BMA says it is extremely ... in law enforcement situations, in the belief that these can ... produced by the BMAs Board of Science, concludes that it is ... the right individuals in a way that is both effective and ...
... In a move to improve global public health, Weill ... heart disease drug onto the World Health Organization's ... guideline for developing countries to choose which high-priority drugs ... ,Students from Weill Cornell's chapter of Universities Allied for ...
... shown that too much heat can decrease sperm count, and retard ... Bourn Hall Clinic in Cambridgeshire have suggested that soaking up the ... fathering a child. ,Many couples believe that a foreign ... up fully. ,However, sperm takes eight weeks to ...
... Field was diagnosed with osteoporosis in 2005, it was a ... had always exercised, and I had always taken calcium,' Field ... a good girl all the way down the line, but ... in town to talk to legislators at a Capitol Hill ...
... of cancer they say will aid the search for cancer-causing ... ,The study was conducted by a team ... at the Dana-Farber Cancer Institute. ,Conventional mouse models ... embryo. , "You plug it into the mouse, ...
Cached Medicine News:Health News:Sacked Employee Says Stress Led to His Sex Addiction 2Health News:Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors 2Health News:Medical College Students Help Change Global Health Policy 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 2Health News:Actress Sally Field Vows to Fight Against Osteoporosis 3Health News:New Mouse Model to Aid in Cancer-causing Genes Hunt 2
HYDRACLEAR is our brandname for a remarkable moisture rich element that lies throughout the interior and exterior of the ACUVUE ADVANCE Brand Contact Lenses creating a unique soft, silky feel....
... For use in the percutaneous retrieval of ... or wire guides, and other foreign objects. ... snare around the lead body. It is delivered ... long, flexible 12 Fr cannula that is placed ...
... existing patented technologies such as Simtec ... with the new innovations of automated ... determination, and intelligent collision avoidance in ... treatment delivery with enhanced patient safety. ...
Clinac EX Platinum accelerators offer all the high performance features of the EX series and come standard with the latest high-precision dose sculpting technology for advanced tumor control....
Medicine Products: